Simmons Bank Vertex Pharmaceuticals Inc Transaction History

Simmons Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$207.02 - $241.31 $181,556 - $211,628	-877 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $16,560 - $22,087	80 Added 10.04%	877 $207,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $27,098 - $32,128	106 Added 15.34%	797 $217,000
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $155,806 - $204,397	691 New	691 $201,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Simmons Bank, based on Form 13F filings with the SEC.

Stay updated on Simmons Bank with notifications on news.